Benitec Biopharma Inc (BNTC)
10.66
+0.26
(+2.50%)
USD |
NASDAQ |
Nov 15, 16:00
10.66
0.00 (0.00%)
After-Hours: 19:56
Benitec Biopharma Total Liabilities (Quarterly): 4.962M for June 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 4.962M |
| March 31, 2024 | 3.499M |
| December 31, 2023 | 5.883M |
| September 30, 2023 | 4.745M |
| June 30, 2023 | 4.262M |
| March 31, 2023 | 3.507M |
| December 31, 2022 | 2.911M |
| September 30, 2022 | 3.502M |
| June 30, 2022 | 3.091M |
| March 31, 2022 | 2.544M |
| December 31, 2021 | 3.178M |
| September 30, 2021 | 2.361M |
| June 30, 2021 | 1.369M |
| March 31, 2021 | 2.498M |
| December 31, 2020 | 0.887M |
| September 30, 2020 | 1.18M |
| June 30, 2020 | 1.349M |
| Date | Value |
|---|---|
| June 30, 2019 | 2.641M |
| December 31, 2018 | 1.514M |
| June 30, 2018 | 1.906M |
| March 31, 2018 | 1.316M |
| December 31, 2017 | 1.420M |
| September 30, 2017 | 1.361M |
| June 30, 2017 | 0.8914M |
| March 31, 2017 | 0.8967M |
| December 31, 2016 | 1.005M |
| September 30, 2016 | 0.7322M |
| June 30, 2016 | 0.7864M |
| March 31, 2016 | 1.706M |
| December 31, 2015 | 0.7303M |
| June 30, 2015 | 1.259M |
| December 31, 2014 | 0.5881M |
| June 30, 2014 | 1.546M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
0.887M
Minimum
Dec 2020
5.883M
Maximum
Dec 2023
3.043M
Average
3.091M
Median
Jun 2022
Total Liabilities (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | 2.805M |
| Palatin Technologies Inc | 10.85M |
| iBio Inc | 7.41M |
| Theriva Biologics Inc | 14.74M |
| Oragenics Inc | 1.383M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 52.21M |
| Shareholders Equity (Quarterly) | 47.25M |